SS-31, also named elamipretide in the supplied certificate, is a four-residue peptide. Its sequence is written D-Arg-Dmt-Lys-Phe-NH2. The D designation, modified residue and terminal amide are essential parts of that description.
Decode the documented four-residue sequence
The supplied SS-31 report prints D-Arg-Dmt-Lys-Phe-NH2 and the elamipretide name. The existing Birk identity source describes the dimethyltyrosine-containing peptide. The notation needs to be carried through into a specification without simplifying away its modifications.SS-31 10 mg report: MA-SS3-0042 (opens in a new tab)Birk et al. (2014), PMID 24134698 (opens in a new tab)
| Field | Reference or document detail |
|---|---|
| Names | SS-31; elamipretide |
| Sequence | D-Arg-Dmt-Lys-Phe-NH2 |
| Residues | 4 |
| D-Arg | D-arginine designation |
| Dmt | Dimethyltyrosine-containing residue notation |
| Terminal NH2 | C-terminal amide |
| CAS, molecular formula and molecular weight | Not verified for the supplied chemical form in the checked dossier |
Which fields complete the reference?
Report MA-SS3-0042, revision 01, identifies lot SS3-42-9HU and records a match to a qualified reference by LC-HRMS. It prints the short sequence but does not give a complete chemical formula, counterion specification or CAS number.SS-31 10 mg report: MA-SS3-0042 (opens in a new tab)
A fuller specification should spell out the modified residue and the complete chemical form used for the reference. Keep that document with the sequence and lot record so a future structural comparison does not depend on the SS-31 nickname alone.SS-31 10 mg report: MA-SS3-0042 (opens in a new tab)Birk et al. (2014), PMID 24134698 (opens in a new tab)
Read identity beside the other results
The linked report lists measured content of 9.99 mg and chromatographic purity of 99.23%. Those fields use different units and describe different measurements. Preserve both labels when transcribing them alongside the identity result.SS-31 10 mg report: MA-SS3-0042 (opens in a new tab)
Select the certificate for the actual product and lot. The printed sequence provides a useful identity anchor, while the report number and reference-comparison details connect it to the named sample.SS-31 10 mg report: MA-SS3-0042 (opens in a new tab)
Product and certificate checks
Sources and further detail
- SS-31 10 mg report: MA-SS3-0042 (opens in a new tab)
Supplied PDF re-read on 3 October 2026. Identity wording and document-specific results are transcribed; this is not independent authentication.
- Birk et al. (2014), PMID 24134698 (opens in a new tab)
Existing dossier used only for peptide identity and the modified-residue description.
Revised 3 October 2026 using the existing source dossier and the specified primary identity records. Report values describe the linked samples. Products are for laboratory research use only.